276 related articles for article (PubMed ID: 33933172)
1. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons.
Cobo A; García-Velasco JA; Remohí J; Pellicer A
Fertil Steril; 2021 May; 115(5):1091-1101. PubMed ID: 33933172
[TBL] [Abstract][Full Text] [Related]
2. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
3. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study.
Cobo A; Giles J; Paolelli S; Pellicer A; Remohí J; García-Velasco JA
Fertil Steril; 2020 Apr; 113(4):836-844. PubMed ID: 32145929
[TBL] [Abstract][Full Text] [Related]
4. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
5. Vitrification of human oocytes.
Coello A; Pellicer A; Cobo A
Minerva Ginecol; 2018 Aug; 70(4):415-423. PubMed ID: 29527869
[TBL] [Abstract][Full Text] [Related]
6. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
7. Oocyte vitrification for elective fertility preservation: the past, present, and future.
Gunnala V; Schattman G
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):59-63. PubMed ID: 27922944
[TBL] [Abstract][Full Text] [Related]
8. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
9. Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
[TBL] [Abstract][Full Text] [Related]
10. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
[TBL] [Abstract][Full Text] [Related]
11. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.
Kim SJ; Kim SK; Lee JR; Suh CS; Kim SH
Reprod Biomed Online; 2020 Jun; 40(6):827-834. PubMed ID: 32295746
[TBL] [Abstract][Full Text] [Related]
12. Oocyte vitrification for oncological and social reasons.
Köroğlu N; Aydın T
Turk J Obstet Gynecol; 2023 Mar; 20(1):59-63. PubMed ID: 36908095
[TBL] [Abstract][Full Text] [Related]
13. Fertility preservation in men and women: Where are we in 2021? Are we rising to the challenge?
Donnez J; Dolmans MM
Fertil Steril; 2021 May; 115(5):1089-1090. PubMed ID: 33823991
[TBL] [Abstract][Full Text] [Related]
14. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F;
Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
[TBL] [Abstract][Full Text] [Related]
15. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
16. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
17. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two different oocyte vitrification methods: a prospective, paired study on the same genetic background and stimulation protocol.
Pujol A; Zamora MJ; Obradors A; Garcia D; Rodriguez A; Vassena R
Hum Reprod; 2019 Jun; 34(6):989-997. PubMed ID: 31116386
[TBL] [Abstract][Full Text] [Related]
19. Oocyte cryopreservation: where are we now?
Argyle CE; Harper JC; Davies MC
Hum Reprod Update; 2016 Jun; 22(4):440-9. PubMed ID: 27006004
[TBL] [Abstract][Full Text] [Related]
20. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
